CD83 and neoplasm: By the analysis of 55 patients with GC, cytoplasmic TGF-β1 expression was observed in tumor cells from 76.4% of cases, and low CD83+ DCs in the tumor border was found in 100% of tumors with TGF-β1 expression (9).